Your browser doesn't support javascript.
loading
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women.
Corsini, Carole; Henouda, Sarra; Nejima, Dalel Ben; Bertet, Héléna; Toledano, Alain; Boussen, Hamouda; Habib, Faouzi; Mouhout, Asma; Gaballah, Ahmed; Ghazaly, Hesham El; Bourgier, Céline; Coupier, Isabelle; Galibert, Virginie; Baudry, Karen; Vilquin, Paul; Biquard, Louise; Rey, Jean-Marc; Belkacemi, Yazid; Ihout, Paul; Khayat, David; Picot, Marie-Christine; Bensalem, Assia; Pujol, Pascal.
Afiliação
  • Corsini C; Department of Cancer Genetics, University of Montpellier and University Hospital (CHU), Montpellier, France.
  • Henouda S; University of Mentouri brothers, Constantine, Algeria.
  • Nejima DB; Department of Biology, University of Sciences of Tunis, Tunis, Tunisia.
  • Bertet H; Department of medical information, University Hospital, Montpellier, France.
  • Toledano A; Department of radiotherapy, Hartmann Radiotherapy Center, American Hospital of Paris, Neuilly, France.
  • Boussen H; Department of oncology, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Habib F; Department of oncology, Oncology Center Al Azhar, Rabat, Morocco.
  • Mouhout A; Department of oncology, Oncology Center Al Azhar, Rabat, Morocco.
  • Gaballah A; Alfa Cure Center and Ain Shams University-Hospitals, Cairo, Egypt.
  • Ghazaly HE; Alfa Cure Center and Ain Shams University-Hospitals, Cairo, Egypt.
  • Bourgier C; Department of radiotherapy, Cancer Institute of Montpellier, ICM Val d'Aurelle, Montpellier, France.
  • Coupier I; Department of Cancer Genetics, University of Montpellier and University Hospital (CHU), Montpellier, France.
  • Galibert V; Department of Cancer Genetics, University of Montpellier and University Hospital (CHU), Montpellier, France.
  • Baudry K; Department of Cancer Genetics, University of Montpellier and University Hospital (CHU), Montpellier, France.
  • Vilquin P; Hormonal and cellular biology laboratory, University Hospital, Montpellier, France.
  • Biquard L; Polytechnique school, Palaiseau, France.
  • Rey JM; Hormonal and cellular biology laboratory, University Hospital, Montpellier, France.
  • Belkacemi Y; Department of radiation oncology and Henri Mondor breast center, APHP Henri Mondor University Hospital, University of Paris-Est Creteil (UPEC), INSERM U955 Eq07, Creteil, France.
  • Ihout P; Department of radiotherapy, Hartmann Radiotherapy Center, American Hospital of Paris, Neuilly, France.
  • Khayat D; Department of radiotherapy, Hartmann Radiotherapy Center, American Hospital of Paris, Neuilly, France.
  • Picot MC; Department of medical information, University Hospital, Montpellier, France.
  • Bensalem A; Department of oncology, EH Didouche Mourad and medical University, Constantine, Algeria.
  • Pujol P; Department of Cancer Genetics, University of Montpellier and University Hospital (CHU), Montpellier, France. p-pujol@chu-montpellier.fr.
Breast Cancer Res Treat ; 166(2): 631-639, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28779219

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Africa / Europa Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína BRCA1 / Proteína BRCA2 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Africa / Europa Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França